Not Yet Recruiting
Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL
NCT07613788
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China